Home » Blood Pressure Drug Misses in Phase III, Aims for New Target
Blood Pressure Drug Misses in Phase III, Aims for New Target
Chelsea Therapeutics is shifting gears with a drug candidate intended for Parkinson’s disease patients, now choosing to focus on a new target after the compound missed its primary goal in late stage clinical trials.
MedCity News
MedCity News
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May